Glenmark Pharmaceuticals Limited has announced a key leadership transition with the appointment of Mr. Anurag Mantri as President (Senior Management Personnel) effective April 7, 2025. The development was approved via a circular resolution by the Board based on the recommendation of the Nomination and Remuneration Committee.
Mr. Mantri brings over three decades of management experience across corporate finance, IPOs, M&A, treasury, and investor relations. He most recently served as Executive Director and Group CFO at Jindal Stainless Limited since 2016 and has held senior leadership roles at HCL Technologies, SRF Ltd, Cairn Energy, ACME Group, and Schneider Electric Infrastructure. He is a qualified chartered accountant and a commerce graduate from the University of Rajasthan.
In a parallel development, Mr. V.S. Mani, the Executive Director and Global Chief Financial Officer, has opted for early retirement and will step down from his position effective close of business on May 26, 2025. Mr. Mani, who has been with Glenmark for nearly eight years, cited personal reasons and age as the basis for his decision. He has expressed willingness to remain with the company for a brief period to ensure a smooth transition.
The company has stated that Mr. Mantri’s candidature for the role of Executive Director and Global CFO will be presented to the Audit Committee, Nomination & Remuneration Committee, and the Board in the upcoming meetings. Upon approval, he will formally assume the CFO and Executive Director responsibilities.
This leadership transition marks a significant shift for Glenmark as it prepares for the next phase of growth and financial stewardship under new leadership.
Disclaimer: The above views are of the company’s and not the author or the publication’s. Please make any and every investment decision after consulting your financial advisor.
